S&P 500

5.346,99

-0,11%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Algorae Pharmaceuticals Limited (QB) (LVCLY)
Algorae Pharmaceuticals Limited (QB) (LVCLY) Notícias

LVCLY

Algorae Pharmaceuticals (QB) (LVCLY)

Algorae Pharmaceuticals Limited (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:LVCLY

Data	Hora	Fonte	Título	Código	Companhia
15/10/2013	00:40	OTC Markets	Annual Report	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
15/10/2013	00:37	OTC Markets	Notice of Annual General Meeting / Proxy Form	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
19/09/2013	21:50	OTC Markets	First patient successfully implanted with NTCELL	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/09/2013	00:37	OTC Markets	Publication of pre-clinical trial of NTCELL in Parkinson's	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
29/08/2013	23:10	OTC Markets	Preliminary Results	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
29/08/2013	00:51	OTC Markets	LCT Announces Change in Regulatory Strategy	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
26/08/2013	23:19	OTC Markets	Preliminary Internal Review of Dia-12 Study	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
31/07/2013	22:23	OTC Markets	Change of Director's Interest Notice	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
30/07/2013	21:06	OTC Markets	Appendix 4C Quarterly Report	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
28/05/2013	22:21	OTC Markets	Change of Directors' Interests Notice	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
09/05/2013	01:37	OTC Markets	Open Briefing LCT Clinical Trials Update	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
28/04/2013	20:41	OTC Markets	Quarterly Report	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
20/03/2013	19:47	OTC Markets	CEO on Strategy - Audio Interview	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
20/03/2013	19:46	OTC Markets	Open Briefing - CEO on Strategy	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
19/03/2013	19:04	OTC Markets	LCT Awarded NZBIO Company of the Year	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
26/02/2013	22:53	OTC Markets	Semi-Annual Report	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
26/02/2013	22:42	OTC Markets	Anouncement on Half-Year Report	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/12/2012	23:48	OTC Markets	Open Briefing interview with MD and CEO Andrea Grant	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/12/2012	23:47	OTC Markets	LCT & Otsuka to co-develop NTCELL for Parkinson's Disease	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
09/12/2012	20:11	OTC Markets	LCT appoints Chief Science and Medical Officer	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
21/11/2012	22:02	OTC Markets	LCT starts DIABECELL Phase IIb trial in Argentina	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
21/11/2012	22:00	OTC Markets	Strong interim results in Argentinian DIABECELL trial	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
19/11/2012	03:28	OTC Markets	Initial Directors Interest Notice	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/11/2012	03:03	OTC Markets	Results of the 2012 Annual General Meeting	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/11/2012	01:40	OTC Markets	AGM Presentation	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
16/11/2012	01:38	OTC Markets	Chairman's Address to the 2012 Annual General Meeting	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
15/11/2012	20:48	OTC Markets	LCT CEO Dr Andrea Grant appointed Managing Director	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
15/11/2012	20:40	OTC Markets	Ethical approval for LCT's NTCELL Phase I trial	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)
04/11/2012	20:37	OTC Markets	Home Country News Release	USOTC:LVCLY	Algorae Pharmaceuticals Limited (QB)